Summary. The expression of specific T-cell receptor gene segments by T lymphocytes appears to be critically important for the induction of several experimental autoimmune diseases mediated by these cells. We examined whether this situation also applied to non-obese diabetic mice by using various T-cell receptor Vfl-specific monoclonal antibodies. No significant age-or sex-related differences were observed in Vfl usage by peripheral and splenic T lymphocytes. CD8 + T lymphocytes among the islet-derived mononuclear cells isolated from 20-week-old female non-obese diabetic mice showed heterogeneity of their V/3 gene usage. In order to examine the role of T lymphocyte subsets expressing specific T-cell receptor V/3 gene segments in the development of diabetes mellitus, T-cell receptor Vfl-specific monoclona! antibodies were administered to 10-week-old male nonobese diabetic mice treated with cyclophosphamide. None of the antibodies used could significantly diminish the incidence of cyclophosphamide-induced diabetes and the severity of insulitis [anti-Vfl3 (11 of 22 mice became diabetic, 50 %), anti-V/35 (9 of 14, 64 %), anti-Vfl8 (9 of 21, 43 %), anti-V/311 (12 of 23, 52%), anti-V]314 (7 of 12, 58%), and anti-V/35 + anti-Villi (6 of 12, 50 %)] when compared with control mice (12 of 21, 57 %). In addition, there were no significant differences in T-cell receptor Vflusage between diabetic and non-diabetic cyclophosphamide-treated mice. These results suggest that five T-lymphocyte subsets expressing different T-cell receptor Vfl gene segments, considered to be candidates involved in the pathogenesis of autoimmune diabetes, do not individually contribute to the development of cyclophosphamide-induced diabetes in non-obese diabetic mice.
monoclonal antibody, cyclophosphamide, insulitis.
Non-obese diabetic (NOD) mice develop infiltration of mononuclear cells into their pancreatic islets (insulitis), and some mice progress to develop Type 1 (insulin-dependent) diabetes mellitus [1] . Therefore, the NOD mouse has been accepted as a model of human Type 1 diabetes and the factors producing the pathology in this animal have been intensively investigated. Type 1 diabetes has been shown to be %lymphocyte mediated [2] [3] [4] and a contribution from both CD4 § and CD8 + T lymphocytes seems to be necessary for the development of overt diabetes [5] [6] [7] [8] [9] . In the search for selective immunotherapy for Type 1 diabetes, it is important to determine which T-lymphocyte subsets contribute to diabetes in the NOD mouse. In this context, we have previously reported that MHC class I K<restricted CD8 + T lymphocytes act as direct effector cells in the destruction of pancreatic beta cells in this mouse strain [10] [11] [12] . The limited heterogeneity of T-cell receptor (TCR) usage in experimental allergic encephalomyelitis (EAE) was recently demonstrated [13] [14] [15] . EAE is an autoimmune disease of the central nervous system that produces symptoms in animals similar to those seen in humans with multiple sclerosis. It has also been reported that monoclonal antibodies (MoAbs) directed against particular TCR V/3 gene segments can be used to prevent and treat this autoimmune disease [13] [14] [15] . Accordingly, investigation of the association between T lymphocytes expressing specific TCR Vfl gene segments and the pathogenesis of diabetes in NOD mice is necessary. However, at present, the TCR Vfl usage in NOD mice is a very controversial topic with divergent results being reported from different groups. In this study, we investigated TCR Vp gene usage by peripheral and splenic T lymphocytes from untreated and cyclophosphamide (CY)-treated NOD mice, and also studied the same genes in islet-derived CD8 + T lymphocytes [10] . Moreover, we attempted to prevent insulitis and overt diabetes in CY-treated male NOD mice by administering several MoAbs directed against various TCR V]3 gene segments.
Materials and methods

Mice
Male and female NOD mice were obtained from the colony kept at the animal facility of Kobe University School of Medicine [16] . The original colony was kindly supplied by the Aburahi Laboratories of Shionogi Research Institute (Shiga, Japan). In our NOD colony, most of the mice develop insulitis at 6-8 weeks of age and the cumulative incidence of diabetes is 5 % in males and 65 % in females at 30 weeks of age. Mice aged 12 weeks or less have not developed overt diabetes in our colony. BALB/c mice were purchased from Clea (Osaka, Japan). MoAbs were harvested as ascites from the nude mice and partially purified by 50 % ammonium sulphate precipitation and dialysis in phosphate-buffered saline (PBS, 120 mmol NaC1, 2.7 mmol KC1 and phosphate buffer salts, 10 retool; pH 7.4). These MoAbs were biotinylated for flow cytometric analysis.
Monoclonal antibodies
Isolation of peripheral and splenic T lymphocytes
Peripheral and splenic T lymphocytes were obtained from orbital venous blood and spleen cells, respectively. T-lymphocyte-rich fractions were extracted from these cells by Ficoll-Hypaque gradient centrifugation and the nylon wool technique, and the fractions obtained had a T lymphocyte content greater than 80 %. These fractions were used for the flow cytometric analysis of peripheral and splenic T lymphocytes.
Isolation of islet-infiltrating mononuclear cells
Pancreatic islets with infiltrating mononuclear cells were isolated from 20-week-old female NOD mice using collagenase and the Ficoll gradient method as described previously [10] . These islets were cultured in 24-well plates with 10 U/ml of human recombinant interleukin-2 (rIL-2; Takeda Chemical Co, Osaka, Japan) in i ml of RPMI 1640 medium containing 10 % fetal calf serum, 50 U/ml penicillin, 50 gg/ml streptomycin and 50 gmol 2-mercaptoethanol. After 4 days, 10 U/ml of rIL-2 in i ml of the above-mentioned medium was added to the culture. After 7 days of culture, islet-derived mononuclear cells were obtained by Ficoll-Hypaque gradient centrifugation. Flow cytometric analysis revealed that 10-30 % of these cells were CD4 + T lymphocytes and 70-90% were CD8 + T lymphocytes.
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Flow cytometry
To determine TCR Vfl gene usage by both peripheral or splenic T lymphocytes from NOD mice and control BALB/c mice, cell surface staining was carried out by incubation with the seven biotinylated-anti-Vfl MoAbs mentioned above, followed by incubation with phycoerythrin-conjugated streptavidin (Vector Laboratories, Burlingame, Calif., USA). Furthermore, peripheral and splenic T lymphocytes were stained with fluorescein-conjugated antiThyl.2 (Becton Dickinson Immunocytometry Systems, Mountain View, Calif., USA) and the percentage of cells expressing each particular Vfl gene segment among whole T lymphocytes was calculated. In CY-treated mice, peripheral and splenic T lymphocytes were subjected to flow cytometric analysis on day 28. To investigate the percentage of each type of TCR Vfl-positive cell among isletderived CD8 § T lymphocytes, the islet-derived mononuclear cells were double-stained with biotinylated anti-Vfl MoAb followed by phycoerythrin-conjugated streptavidin and also a fluorescein-conjugated anti-CD8 (Lyt 2) MoAb (Becton Dickinson). The percentage of positive cells was determined with a FACS 440 flow cytometer (Becton Dickinson).
Effect of MoAbs on CY-induced diabetes
Ten-week-old male NOD mice were injected with CY (Asta, Frankfurt, FRG) at a dose of 200 mg/kg body weight on days 0 and 14. The mice were assigned to seven groups, and received either PBS (control), anti-Vfl3, anti-V/35, anti-Vfl8, anti-Villi, or anti-V/314 MoAb or a combination of both the anti-Vfl5 and anti-Villi MoAbs. The control PBS (200 gl) and the five types of anti-Vfl MoAbs (1 mg in 200 gl PBS) were administered intraperitoneally on days 0 and 14. The mice were tested for glucosuria two times per week until day 28 using Tes-Tape (Eli-Lilly, Indianapolis, Ind., USA). In mice showing a positive result with the Tes-Tape, the non-fasting level was determined by the glucose oxidase method. A glucose level greater than 16.7 mmol/1 was taken to indicate diabetes. On day 28, the mice were killed for histological examination and the depletion of T lymphocytes expressing corresponding Vfl gene products was checked by flow cytometric analysis.
Histological examination
On day 28, the pancreases removed from CY-treated mice injected with PBS or the anti-Vfl MoAb(s) were fixed in Bouin's solution. Paraffin-embedded sections were stained with haematoxylin and eosin and the severity of insulitis was assessed using the scoring system of Charlton et al. [9] : (0), islets with no peri-islet mononuclear cells; (1), focal peri-islet aggregates affecting less than 25% of the islet circumference; (2), more extensive peri-islet aggregates; (3), intra-islet infiltration with preservation of the beta cells; (4), extensive intra-islet infiltration with obvious beta-cell damage and gross architectural distortion. The scores were converted to a percentage, with 100 % indicating total islet destruction.
Statistical analysis
The significant differences in the incidence of diabetes was determined with the chi-square test. Statistical analysis of the insulitis scores was done using the non-parametric Mann-Whitney U-test, while the other results were statistically evaluated by Student's t-test. All data are presented as the mean _+ SD. Values are means + SD. There were no significant differences in TCR V//gene usage in relation to age or sex. a n is the number of mice examined except for islet-derived CD8 + T lymphocytes where n is the number of experiments performed n is the number of mice examined. PBS, phosphate-buffered saline; MoAb, monodonal antibody
Results
We first investigated which TCR Vfl gene segments are expressed by peripheral and splenic T lymphocytes in NOD mice using various TCR Vfl-specific MoAbs. Table 1 shows that the pattern of expression of Vfl gene segments by peripheral T lymphocytes did not change with age and no differences were seen between the sexes. Splenic T lymphocytes from 10-week-old NOD mice also showed no significant sex difference in TCR Vfl usage (Table 1) . It is notable that T lymphocytes expressing the Vfl5 and Vflll gene segments existed ha NOD mice, which do not have MHC class II I-E molecules. On the other hand, Vfl5 and Vflll positive T lymphocytes were almost depleted in I-E positive BALB/c mice. We isolated mono•uclear cells fl'om the pancreatic islets of 20-week-old female NOD mice. The CD8 + T lymphocytes among these mononuclear cells were previously shown to destroy pancreatic islet cells in a MHC class I K < restricted manner in vitro [10] . Therefore, we investigated whether particular TCR Vfl gene segments were expressed by islet-derived CD8 + T lymphocytes. Table 1 also shows the percentage of CD8 + T lymphocytes expressing each Vfl gene segment. A remarkable heterogeneity was observed in TCR usage by these cells.
To further examine the role ofT-lymphocyte subsets expressing specific TCR Vfl gene segments in the development of diabetes in these mice, we attempted to prevent CY-induced diabetes by administering MoAbs against five different TCR Vj3 gene segments. As shown in Figure 1 , CY-treated mice injected with PBS or with the anti-Vfl MoAb(s) developed diabetes after day 10 and the incidence continued to increase until day 28. The flow cytometric analysis showed the depletion of T lymphocytes expressing corresponding Vflgene products (data not shown). Table 2 summarizes the cumulative incidence of diabetes on day 28. It was not reduced significantly by any of the MoAb(s), although anti-Vfl8 treated mice had a lower incidence of diabetes than the control mice. Similarly, the severity of insulitis was not significantly diminished by any of the MoAb(s). Although some of the CY-treated mice developed diabetes very rapidly, no significant changes were observed in their TCR Vfl gene usage on day 28 when compared with that of untreated mice (Fig. 2) . Moreover, there were no significant differences between CY-treated diabetic mice and CY-treated non-diabetic mice with regard to TCR V]3usage (Fig. 2) .
Discussion
Recently, the structure of the TCR has been intensively studied and much attention has been given to the relationship between the pathogenesis of autoimmune disease
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and TCR V gene usage. In particular, the limited usage of TCR Vfl gene segments in EAE [13] [14] [15] , a disease which shows symptoms similar to those of multiple sclerosis, suggested the possibility that similar restricted TCR usage might occur in other models of autoimmune disease. In such cases, the administration of anti-TCR MoAbs would have the potential to be used for selective immunotherapy. However, whether the findings observed in EAE are applicable to NOD mice is not known. It has been reported that T lymphocytes expressing either the V/35, Vflll, V]312, V]316, or VC/17a gene segments are depleted in mice which have I-E molecules [22] [23] [24] [25] . In addition, the prevention of insulitis and diabetes in I-E-positive transgenic NOD mice [26, 27] suggested that a lack of I-E molecule might lead to an inability to deplete the diabetogenic T lymphocytes expressing certain Vfl gene segments. On the other hand, Reich et al. [28, 29] have reported that both the CD4 § and CD8 + clones of islet-specific T cells derived from the islets of recently diabetic NOD mice, expressed TCR Vfll gene segments. Bacelj et al. [30] reported that the administration of an anti-Vfl8 MoAb could prevent CY-induced diabetes in NOD mice and that V]38 + T lymphocytes appeared to have a role in the development of disease, similar to the situation with EAE. In contrast, Nakano et al. [31] reported that islet-reactive Tcell clones derived from NOD mice showed remarkable heterogeneity in their TCR V~ and V/3 usage. Lipes et al. [32, 33] introduced a rearranged TCR Vfl chain transgene derived from a T-lymphocyte hybridoma specific to chicken ovalbumin into the NOD background by progressive backcrossing. Although the transgene segments replaced the normally expressed V/3 gene segments, the transgenic NOD mice developed autoimmunity similar to control littermates. These results suggested that the TCR V/3gene repertoire alone does not determine the susceptibility of NOD mice to autoimmune diabetes. Therefore, to examine the implications of T lymphocytes expressing a particular TCR V/3gene segment in the pathogenesis of diabetes in NOD mice, we first determined the TCR Vfl gene usage by peripheral and splenic T lymphocytes in NOD mice by using seven different anti-TCR Vfl MoAbs. In NOD mice, insulitis became noticeable in the majority of mice at age 6-8 weeks, and was greatly enhanced by 10-15 weeks, with the incidence of diabetes showing a large sex-related difference. Accordingly, we examined the changes of TCR V/~ usage during advancing age as well as comparing it between the sexes. However, no significant age-or sex-based differences in TCR usage were found. Our flow cytometric data with some anti-V/3 antibodies varies from the results with these same antibodies from other laboratories [31, 34] . This discrepancy may be due to the differences in the NOD colonies or of sources of T cells examined (peripheral blood cells, splenic cells, and lymph node cells) or both.
Rapidly progressing overt diabetes was induced by CY in approximately 60 % of the 10-week-old male NOD mice, most likely by inhibiting T suppressor cell activity [35] . Furthermore, it has already been reported that CY administration caused a rapid decrease of the proportion of Thyl.2, CD4 + and CD8 + cells among splenocytes [8, 11] . Therefore, we investigated whether diabetogenic el-lector cells expressing a particular Vfl gene segment increased dramatically after CY administration. However, it was found that CY injection caused no significant changes in TCR Vfl gene usage.
Next, we isolated islet-infiltrating mononuclear cells from 20-week-old female NOD mice. As we reported previously [10] , these cells are mainly CD8 § T lymphocytes and are capable of destroying pancreatic beta cells in an MHC class I Ka-restricted manner in vitro. Therefore, we investigated whether the CD8 + T lymphocytes among these cells have a restricted usage of Vfl gene segments. We found that these CD8 § T lymphocytes actually showed a marked heterogeneity of TCR Vfl usage. It is not clear whether CD8 + T lymphocyte populations established from NOD islets are really a mixture of islet reactive T lymphocytes or a heterogeneous population containing both specific and non-specific T lymphocytes. These CD8 + islet-derived T lymphocytes, however, appear to be mainly composed of beta-cell specific cytotoxic T lymphocytes. This was demonstrated morphologically by the rapid and intense cytolysis of beta cells caused by these T lymphocytes [12] . Therefore, at present, we are unable to establish that a single T-lymphocyte subset with a special Vfl gene segment is associated with beta-cell destruction in NOD mice. In addition, O'Reilly et al. [36] have reported that T lymphocytes expressing the Vfl8, Vfl6 and Vflll gene segments were detected by immunohistochemical analysis in the infiltrates of spontaneously diabetic female NOD mice, non-diabetic male NOD mice, and recipients of spleen cells from diabetic NOD donors, again suggesting heterogeneity of TCR usage by these cells.
We attempted to shorten the time until the onset of overt diabetes using CY [35, 37] . We selected the antiVfl3, Vfl5, Vfl8, Vf111, and Vf114 MoAbs for this experiment for the following reasons: (1) Vfl5 + and Vflll + T lymphocytes are absent in I-E + mice, (2) Vfl8 + T lymphocytes are reported to be implicated in EAE, and (3) Vfl3 + and Vf114 + T lymphocytes are common among the peripheral and splenic T lymphocytes of NOD mice. None of the five MoAbs specific for TCR Vfl gene segments (including the combination of anti-Vfl5 and antiVflll MoAbs) were found to be capable of significantly reducing the severity of insulitis and the incidence of CYinduced diabetes. However, since the present analysis of T-cell subsets did not involve nearly one-half of the TCR and other Vfl TCR could be the key elements in disease expression, the analysis of the T-cell repertoire that were not tested here could be important.
Our findings suggest that none of five T lymphocyte subsets expressing Vfl3, 5, 8, 11, and 14 are likely to play a crucial role independent of other subsets in the pathogenesis of diabetes in NOD mice. Our conclusion is apparently contrary to the published report of Bacelj et al., [30] in which administration of anti-Vfl8 MoAb could prevent CY-induced diabetes. This discrepancy may be due to the differences in the NOD colonies, the difference in animal age at CY administration (10 weeks in our study, 100-120 days in Bacelj's study) or the dose and interval of CY administration (200 mg/kg on days 0 and 14 in our study, 350 mg/kg on day 0 in Bacelj's study). Some recent-ly published backcross-intercross studies [38, 39] have bred NOD mice to mouse strains that congenitally lack some of the conventional TCR Vfl alleles. Backcross-intercross animals with NOD genetic background could develop insulitis and diabetes, although they lacked natural T lymphocytes expressing Vfl5, 8, 9, 11, 12 and 13 gene segments. These data appear to support our conclusions.
Candeias et al. [40] recently reported that the sequences of the TCR c~ and fl chains from NOD derived isletspecific clones were quite heterogeneous, a finding which also supports our conclusions. In contrast to EAE, in which a single peptide is injected artificially, the antigens associated with the pathogenesis of spontaneously developing diabetes in NOD mice are probably far more complex. As Candeias et al. [40] noted, however, the T lymphocytes which recognize the actual disease-initiating antigen at an early stage of diabetes may show limited heterogeneity of TCR usage. However, once the disease cascade has started, multiple T-lymphocyte subsets that recognize other antigens could also participate in the development of overt diabetes. Thus, examination of the TCR heterogeneity of T lymphocytes isolated from the pancreases of very young NOD mice is of interest.
